Proteomics and prostate cancer

Genomics and Proteomics: Principles, Technologies, and Applications

Volumn , Issue , 2015, Pages 143-174

  Myung, Jae Kyung ^a   Sadar, Marianne D ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Epitope tagging techniques; Expression proteomics; Flag Tag; Fluorescence resonance energy transfer; Functional proteomics; Glutathione S transferase pull down; Isotope tags for relative and absolute protein quantitation; Isotope coded affinity tag; Isotope tagged proteomics; Laser capture microdissection; Mass spectrometry; Multidimensional protein identification technology; Phage display; Prostate cancer; Prostate specific antigen; Protein arrays; Stable isotope labeling by amino acids in cell culture; Tandem affinity purification; Two dimensional difference gel electrophoresis; Two dimensional gel electrophoresis; Yeast two hybrid system

Indexed keywords

EID: 85052807745     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b18597     Document Type: Chapter

References (189)

1. Aebersold, R.; Mann, M. Mass spectrometry-based proteomics. Nature 2003, 422, 198-207.
2. Ahram, M.; Best, C. J.; Flaig, M. J.; Gillespie, J. W.; Leiva, I. M.; Chuaqui, R. F.; Zhou, G.; Shu, H.; Duray, P. H.; Linehan, W. M.; Raffeld, M.; Ornstein, D. K.; Zhao, Y.; Petricoin, E. F. 3rd, Emmert-Buck, M. R. Proteomic analysis of human prostate cancer. Mol Carcinog 2002, 33, 9-15.
3. Alberts, B. The cell as a collection of protein machines: Preparing the next generation of molecular biologists. Cell 1998, 92, 291-294.
4. Aloy, P.; Russell, R. B. Structural systems biology: Modelling protein interactions. Nat Rev Mol Cell Biol 2006, 7, 188-197.
5. Amanchy, R.; Kalume, D. E.; Pandey, A. Stable isotope labeling with amino acids in cell culture (SILAC) for studying dynamics of protein abundance and posttranslational modifications. Sci STKE 2005, 267, l2.
6. Anderson, N. L.; Anderson, N. G. The human plasma proteome: History, character, and diagnostic prospects. Mol Cell Proteomics 2002, 1, 845-867.
7. Bader, G. D.; Hogue, C. W. Analyzing yeast protein-protein interaction data obtained from different sources. Nat. Biotechnol 2002, 20, 991-997.
8. Bañez, L. L.; Srivastava, S.; Moul, J. W. Proteomics in prostate cancer. Curr Opin Urol 2005, 15, 151-156.
9. Bauch, A.; Superti-Furga, G. Charting protein complexes, signaling pathways, and networks in the immune system. Immunol Rev 2006, 210, 187-207.
10. Best, C. J.; Emmert-Buck, M. R. Molecular profiling of tissue samples using laser capture microdissection. Expert Rev Mol Diagn 2001, 1, 53-60.
11. Blagoev, B.; Kratchmarova, I.; Ong, S. E.; Nielsen, M.; Foster, L. J.; Mann, M. A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. Nat Biotechnol 2003, 21, 315-318.
12. Blanar, M. A.; Rutter, W. J. Interaction cloning: Identification of a helix-loop-helix zipper protein that interacts with c-fos. Science 1992, 256, 1014-1018.
13. Bradford, T. J.; Tomlins, S. A.; Wang, X.; Chinnaiyan, A. M. Molecular markers of prostate cancer. Urol Oncol 2006, 24, 538-551.
14. Cazares, L. H.; Adam, B. L.; Ward, M. D.; Nasim, S.; Schellhammer, P. F.; Semmes, O. J.; Wright, G. L. Jr. Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry. Clin Cancer Res 2002, 8, 2541-2552.
15. Celis, J. E.; Gromov, P. 2D protein electrophoresis: Can it be perfected? Current Opinion in Biotechnology 1999, 10, 16-21.
16. Celis, J. E.; Gromov, P. High-resolution two-dimensional gel electrophoresis and protein identification using western blotting and ECL detection. Exs 2000, 88, 55-67.
17. Celis, J. E.; Gromov, P. Proteomics in translational cancer research: Toward an integrated approach. Cancer Cell 2003, 3, 9-15.
18. Celis, J. E.; Rasmussen, H. H.; Gromov, P.; Olsen, E.; Madsen, P.; Leffers, H.; Honore, B.; Dejgaard, K.; Vorum, H.; Kristensen, D. B.; Østergaard, M.; Haunsø, A.; Jensen, N. A.; Celis, A.; Basse, B.; Lauridsen, J. B.; Ratz, G. P.; Andersen, A. H.; Walbum, E.; Kjærgaard, I.; Andersen, I.; Puype, M.; Damme, J.; Vandekerckhove, J. The human keratinocyte two-dimensional gel protein database: Mapping components of signal transduction pathways. Electrophoresis 1995, 16, 2177-2240.
19. Chaga, G.; Bochkariov, D. E.; Jokhadze, G. G.; Hopp, J.; Nelson, P. Natural poly-histidine affinity tag for purification of recombinant proteins on cobalt(II)-carboxymethylaspartate crosslinked agarose. J Chromatogr A 1999, 864, 247-256.
20. Chan, J. M.; Stampfer, M. J.; Giovannucci, E.; Gann, P. H.; Ma, J.; Wilkinson, P.; Hennekens, C. H.; Pollak, M. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study. Science 1998, 279, 563-566.
21. Chatterjee, S.; Schoepe, J.; Lohmer, S.; Schomburg, D. High level expression and single-step purification of hexahistidine-tagged l-2-hydroxyisocaproate dehydrogenase making use of a versatile expression vector set. Protein Expr Purif 2005, 39, 137-143.
22. Cheung, P. K.; Woolcock, B.; Adomat, H.; Sutcliffe, M.; Bainbridge, T. C.; Jones, E. C.; Webber, D.; Kinahan, T.; Sadar, M.; Gleave, M. E.; Vielkind, J. Protein profiling of microdissected prostate tissue links growth differentiation factor 15 to prostate carcinogenesis. Cancer Res 2004, 64, 5929-5933.
23. Chien, C. T.; Bartel, P. L.; Sternglanz, R.; Fields, S. The two-hybrid system: A method to identify and clone genes for proteins that interact with a protein of interest. Proc Natl Acad Sci USA 1991, 88, 9578-9582.
24. Cohen, P. The Croonian Lecture 1998. Identification of a protein kinase cascade of major importance in insulin signal transduction. Philos Trans R Soc Lond B Biol Sci 1999, 354, 485-495.
25. Colland, F.; Daviet, L. Integrating a functional proteomic approach into the target discovery process. Biochimie 2004, 86, 625-632.
26. Comuzzi, B.; Sadar, M. D. Proteomic analyses to identify novel therapeutic targets for the treatment of advanced prostate cancer. Cell Science 2006, 3, 61-81.
27. Corder, E. H.; Guess, H. A.; Hulka, B. S.; Friedman, G. D.; Sadler, M.; Vollmer, R. T.; Lobaugh, B.; Drezner, M. K.; Vogelman, J. H.; Orentreich, N. Vitamin D and prostate cancer: A prediagnostic study with stored sera. Cancer Epidemiol. Biomarkers Prev 1993, 2, 467-472.
28. Craft, N.; Shostak, Y.; Carey, M.; Sawyers, C. L. A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. Nat Med 1999, 5, 280-285.
29. Culig, Z.; Hobisch, A.; Cronauer, M. V.; Radmayr, C.; Trapman, J.; Hittmair, A.; Bartsch, G.; Klocker, H. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor and epidermal growth factor. Cancer Res 1994, 54, 5474-5478.
30. Day, R. N. Visualization of Pit-1 transcription factor interactions in the living cell nucleus by fluorescence resonance energy transfer microscopy. Mol Endocrinol 1998, 12, 1410-1419.
31. Diaz, J. I.; Cazares, L. H.; Corica, A.; John Semmes, O. Selective capture of prostatic basal cells and secretory epithelial cells for proteomic and genomic analysis. Urol Oncol 2004, 22, 329-336.
32. Diamond, D. L.; Kimball, J. R.; Krisanaprakornkit, S.; Ganz, T.; Dale, B. A. Detection of beta-defensins secreted by human oral epithelial cells. J Immunological Meth 2001, 256, 65-76.
33. Dziembowski, A.; Séraphin, B. Recent developments in the analysis of protein complexes. FEBS Lett 2004, 556, 1-6.
34. Dziembowski, A.; Ventura, A. P.; Rutz, B.; Caspary, F.; Faux, C.; Halgand, F.; Laprévote, O.; Séraphin, B. Proteomic analysis identifies a new complex required for nuclear pre-mRNA retention and splicing. EMBO J 2004, 23, 4847-4856.
35. Edwards, A. M.; Kus, B.; Jansen, R.; Greenbaum, D.; Greenblatt, J.; Gerstein, M. Bridging structural biology and genomics: Assessing protein interaction data with known complexes. Trends Genet 2002, 18, 529-536.
36. Einhauer, A.; Jungbauer, A. The FLAG peptide, a versatile fusion tag for the purification of recombinant proteins. J. Biochem. Biophys. Methods 2001,49, 455-465.
37. Eliseev, R.; Alexandrov, A.; Gunter, T. High-yield expression and purification of p18 form of Bax as an MBP-fusion protein. Protein Expr Purif 2004, 35, 206-209.
38. Emmert-Buck, M. R.; Bonner, R. F.; Smith, P. D.; Chuaqui, R. F.; Zhuang, Z.; Goldstein, S. R.; Weiss, R. A.; Liotta, L. A. Laser capture microdissection. Science 1996, 274, 998-1001.
39. Etzioni, R.; Penson, D. F.; Legler, J. M.; di Tommaso, D.; Boer, R.; Gann, P. H.; Feuer, E. J. Overdiagnosis due to prostate-specific antigen screening: Lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 2002, 94, 981-990.
40. Everley, P. A.; Krijgsveld, J.; Zetter, B. R.; Gygi, S. P. Quantitative cancer proteomics: Stable isotope labeling with amino acids in cell culture (SILAC) as a tool for prostate cancer research. Mol Cell Proteomics 2004, 3, 729-735.
41. Feher, A.; Boross, P.; Sperka, T.; Oroszlan, S.; Tozser, J. Expression of the murine leukemia virus protease in fusion with maltose-binding protein in Escherichia coli. Protein Expr Purif 2004, 35, 62-68.
42. Feldman, B. J.; Feldman, D. The development of androgen-independent prostate cancer. Nat. Rev Cancer 2001, 1, 34-45.
43. Fields, S.; Song, O. A novel genetic system to detect protein-protein interactions. Nature 1989, 340, 245-246.
44. Forster, T. Intermolecular energy migration and fluorescence. Ann Physik 1948, 2, 55-75.
45. Fracalanza, S.; Prayer-Galetti, T.; Pinto, F.; Navaglia, F.; Sacco, E.; Ciaccia, M.; Plebani, M.; Pagano, F.; Basso, D. Plasma chromogranin A in patients with prostate cancer improves the diagnostic efficacy of free/total prostate-specific antigen determination. Urol Int 2005, 75, 57-61.
46. Fritze, C. E.; Anderson, T. R. Epitope tagging: General method for tracking recombinant proteins. Methods Enzymol 2000, 327, 3-16.
47. Fu, M.; Wang, C.; Zhang, X.; Pestell, R. G. Acetylation of nuclear receptors in cellular growth and apoptosis. Biochem Pharmacol 2004, 68, 1199-1208.
48. Fujimoto, N.; Yeh, S.; Kang, H. Y.; Inui, S.; Chang, H. C.; Mizokami, A.; Chang, C. Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate. J Biol Chem 1999, 274:8316-8321.
49. Fuller, A. P.; Palmer-Toy, D.; Erlander, M. G.; Sgroi, D. C. Laser capture microdissection and advanced molecular analysis of human breast cancer. J Mammary Gland Biol Neoplasia 2003, 8, 335-345.
50. Gagné, J. P.; Ethier, C.; Gagné, P.; Mercier, G.; Bonicalzi, M. E.; Mes-Masson, A. M.; Droit, A.; Winstall, E.; Isabelle, M.; Poirier, G. G. Comparative proteome analysis of human epithelial ovarian cancer. Proteome Sci 2007, 5, 16.
51. Gelmann, E. P. Molecular biology of the androgen receptor. J Clin Oncol 2002, 20, 3001-3015.
52. Ghosh, P. M.; Malik, S.; Bedolla, R.; Kreisberg, J. I. Akt in prostate cancer: Possible role in androgen-independence. Curr Drug Metab 2003, 4, 487-496.
53. Gioeli, D.; Ficarro, S. B.; Kwiek, J. J.; Aaronson, D.; Hancock, M.; Catling, A. D.; White, F. M.; Christian, R. E.; Settlage, R. E.; Shabanowitz, J.; Hunt, D. F.; Weber, M. J. Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites. J Biol Chem 2002, 277, 29304-29314.
54. Görg, A.; Obermaier, C.; Boguth, G.; Harder, A.; Scheibe, B.; Wildgruber, R.; Weiss, W. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 2000, 21, 1037-1053.
55. Graumann, J.; Dunipace, L. A.; Seol, J. H.; McDonald, W. H.; Yates, J. R. 3rd, Wold, B. J.; Deshaies, R. J. Applicability of tandem affinity purification MudPIT to pathway proteomics in yeast. Mol Cell Proteomics 2004, 3, 226-237.
56. Griffiths, S. D.; Burthem, J.; Unwin, R. D.; Holyoake, T. L.; Melo, J. V.; Lucas, G. S.; Whetton, A. D. The use of isobaric tag peptide labeling (iTRAQ) and mass spectrometry to examine rare, primitive hematopoietic cells from patients with chronic myeloid leukemia. Mol Biotechnol 2007, 36, 81-89.
57. Griffin, T. J.; Han, D. K.; Gygi, S. P.; Rist, B.; Lee, H.; Aebersold, R.; Parker, K. C. Toward a high-throughput approach to quantitative proteomic analysis: Expression-dependent protein identification by mass spectrometry. Journal of the American Society for Mass Spectrometry 2001, 12, 1238-1246.
58. Grubb, R. L.; Calvert, V. S.; Wulkuhle, J. D.; Paweletz, C. P.; Linehan, W. M.; Phillips, J. L.; Chuaqui, R.; Valasco, A.; Gillespie, J.; Emmert-Buck, M.; Liotta, L. A.; Petricoin, E. F. Signal pathway profiling of prostate cancer using reverse phase protein arrays. Proteomics 2003, 3, 2142-2146.
59. Gruhler, A.; Olsen, J. V.; Mohammed, S.; Mortensen, P.; Faergeman, N. F.; Mann, M.; Jensen, O. N. Quantitative phosphoproteomics applied to the yeast pheromone signaling pathway. Mol Cell Proteomics 2005, 4, 310-327.
60. Gygi, S. P.; Rist, B.; Gerber, S. A.; Turecek, F.; Gelb, M. H.; Aebersold, R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nature Biotechnology 1999, 17, 994-999.
61. Harman, S. M.; Metter, E. J.; Landis, P. K.; Carter, H. B. Baltimore Longitudinal Study on Aging. Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer. J Clin Endocrinol Metab 2000, 85, 4258-4265.
62. He, B.; Minges, J. T.; Lee, L. W.; Wilson, E. M. The FXXLF motif mediates androgen receptor-specific interactions with coregulators. J Biol Chem 2002, 277, 10226-10235.
63. Heemers, H. V.; Tindall, D. J. Androgen receptor (AR) coregulators: A diversity of functions converging on and regulating the AR transcriptional complex. Endocr Rev 2007, 28, 778-808.
64. Hochstrasser, D. F.; Sanchez, J. C.; Appel, R. D. Proteomics and its trends facing nature’s complexity. Proteomics 2002, 2, 807-812.
65. Hoeben, A.; Landuyt, B.; Botrus, G.; De Boeck, G.; Guetens, G.; Highly, M.; van Oosterom, A. T.; de Bruijn, E. A. Proteomics in cancer research: Methods and application of array-based protein profiling technologies. Anal Chim Acta 2006, 564, 19-33.
66. Huang, H.; Muddiman, D. C.; Tindall, D. J. Androgens negatively regulate forkhead transcription factor FKHR (FOXO1) through a proteolytic mechanism in prostate cancer cells. J Biol Chem 2004, 279, 138, 66-13877.
67. Humphries, H. E.; Christodoulides, M.; Heckels, J. E. Expression of the class 1 outer-membrane protein of Neisseria meningitidis in Escherichia coli and purification using a self-cleavable affinity tag. Protein Expr Purif 2002, 26, 243-248.
68. Hunt, J. L.; Finkelstein, S. D. Microdissection techniques for molecular testing in surgical pathology. Arch Pathol Lab Med 2004, 128, 1372-1378.
69. Ibarrola, N.; Kalume, D. E.; Gronborg, M.; Iwahori, A.; Pandey, A. A proteomic approach for quantitation of phosphorylation using stable isotope labeling in cell culture. Anal Chem 2003, 75, 6043-6049.
70. Ito, T.; Chiba, T.; Ozawa, R.; Yoshida, M.; Hattori, M.; Sakaki, Y. A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc Natl Acad Sci USA 2001, 98, 4569-4574.
71. Jemal, A.; Siegel, R.; Ward, E.; Murray, T.; Xu, J.; Thun, M. J. Cancer statistics, 2007. CA Cancer J Clin 2007, 57, 43-66.
72. Junttila, M. R.; Saarinen, S.; Schmidt, T.; Kast, J.; Westermarck, J. Single-step Strep-tag purification for the isolation and identification of protein complexes from mammalian cells. Proteomics 2005, 5, 1199-1203.
73. Kemmeren, P.; van Berkum, N. L.; Vilo, J.; Bijma, T.; Donders, R.; Brazma, A.; Holstege, F. C. Protein interaction verification and functional annotation by integrated analysis of genome-scale data. Mol Cell 2002, 9, 1133-1143.
74. Keshamouni, V. G.; Michailidis, G.; Grasso, C. S.; Anthwal, S.; Strahler, J. R.; Walker, A.; Arenberg, D. A.; Reddy, R. C.; Akulapalli, S.; Thannickal, V. J.; Standiford, T. J.; Andrews, P. C.; Omenn, G. S. Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype. J Proteome Res 2006, 5, 1143-1154.
75. Knappik, A.; Plückthun, A. An improved affinity tag based on the FLAG peptide for the detection and purification of recombinant antibody fragments. Biotechniques 1994, 17, 754-761.
76. Kolkman, A.; Dirksen, E. H.; Slijper, M.; Heck, A. J. Double standards in quantitative proteomics: Direct comparative assessment of difference in gel electrophoresis and metabolic stable isotope labeling. Mol Cell Proteomics 2005, 4, 255-266.
77. Kunz, D.; Gerad, N. P.; Gerad, C. The human leukocyte platelet activating factor receptor. J Biol Chem 1992, 267, 9101-9106.
78. Kurek, R.; Nunez, G.; Tselis, N.; Konrad, L.; Martin, T.; Roeddiger, S.; Aumüller, G.; Zamboglou, N.; Lin, D. W.; Tunn, U. W.; Renneberg, H. Prognostic value of combined “triple”-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients. Clin Cancer Res 2004, 10, 5808-5814.
79. Le, L.; Chi, K.; Tyldesley, S.; Flibotte, S.; Diamond, D. L.; Kuzyk, M. A.; Sadar, M. D. Identification of serum amyloid A as a biomarker to distinguish prostate cancer patients with bone lesions. Clin Chem 2005, 51, 695-707.
80. Lee, J. W.; Lee, S. K. Mammalian two-hybrid assay for detecting protein-protein interactions in vivo. Methods Mol Biol 2004, 261, 327-336.
81. Leman, E. S.; Cannon, G. W.; Trock, B. J.; Sokoll, L. J.; Chan, D. W.; Mangold, L.; Partin, A. W.; Getzenberg, R. H. EPCA-2: A highly specific serum marker for prostate cancer. Urology 2007, 69, 714-720.
82. Li, S.; Shang, Y. Regulation of SRC family coactivators by post-translational modifications. Cell Signal 2007, 19, 1101-1112.
83. Ling, M. T.; Kwok, W. K.; Fung, M. K.; Xianghong, W.; Wong, Y. C. Proteasome mediated degradation of Id-1 is associated with TNFalpha-induced apoptosis in prostate cancer cells. Carcinogenesis 2006, 27, 205-215.
84. Liotta, L. A.; Espina, V.; Mehta, A. I.; Calvert, V.; Rosenblatt, K.; Geho, D.; Munson, P. J.; Young, L.; Wulfkuhle, J.; Petricoin, E. F. 3rd. Protein microarrays: Meeting analytical challenges for clinical applications. Cancer Cell 2003, 3, 317-325.
85. MacBeath, G.; Schreiber, S. L. Printing proteins as microarrays for high-throughput function determination. Science 2000, 289, 1760-1763.
86. Malik, G.; Ward, M. D.; Gupta, S. K.; Trosset, M. W.; Grizzle, W. E.; Adam, B. L.; Diaz, J. I.; Semmes, O. J. Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer. Clin Cancer Res 2005, 11, 1073-1085.
87. Marcotte, E. M.; Pellegrini, M.; Ng, H. L.; Rice, D. W.; Yeates, T. O.; Eisenberg, D. Detecting protein function and protein-protein interactions from genome sequences. Science 1999, 285, 751-753.
88. Marszalek, M.; Wachter, J.; Ponholzer, A.; Leitha, T.; Rauchenwald, M.; Madersbacher, S. Insulin-like growth factor 1, chromogranin A and prostate specific antigen serum levels in prostate cancer patients and controls. Eur Urol 2005, 48, 34-39.
89. Martin, D. B.; Gifford, D. R.; Wright, M. E.; Keller, A.; Yi, E.; Goodlett, D. R.; Aebersold, R.; Nelson, P. S. Quantitative proteomic analysis of proteins released by neoplastic prostate epithelium. Cancer Res 2004, 64, 347-355.
90. Meehan, K. L.; Sadar, M. D. Quantitative profiling of LNCaP prostate cancer cells using isotope-coded affinity tags and mass spectrometry. Proteomics 2004, 4, 1116-1134.
91. Mirgorodskaya, O. A.; Kozmin, Y. P.; Titov, M. I.; Körner, R.; Sönksen, C. P.; Roepstorff, P. Quantitation of peptides and proteins by matrix-assisted laser desorption/ionization mass spectrometry using (18)O-labeled internal standards. Rapid Commun. Mass Spectrom 2000, 14, 1226-1232.
92. M’Koma, A. E.; Blum, D. L.; Norris, J. L.; Koyama, T.; Billheimer, D.; Motley, S.; Ghiassi, M.; Ferdowsi, N.; Bhowmick, I.; Chang, S. S.; Fowke, J. H.; Caprioli, R. M.; Bhowmick, N. A. Detection of pre-neoplastic and neoplastic prostate disease by MALDI profiling of urine. Biochem Biophys Res Commun 2007, 353, 829-834.
93. Mocellin, S.; Rossi, C. R.; Traldi, P.; Nitti, D.; Lise, M. Molecular oncology in the post-genomic era: The challenge of proteomics. Trends Mol Med 2004, 10, 24-32.
94. Moilanen, A. M.; Poukka, H.; Karvonen, U.; Häkli, M.; Jänne, O. A.; Palvimo, J. J. Identification of a novel RING finger protein as a coregulator in steroid receptor-mediated gene transcription. Mol Cell Biol 1998, 18, 5128-5139.
95. Moseley, M. A. Current trends in differential expression proteomics: Isotopically coded tags. Trends in Biotechnology 2001, 19, S10-16.
96. Mrowka, R.; Patzak, A.; Herzel, H. Is there a bias in proteome research? Genome Res 2001, 11, 1971-1973.
97. Nazareth, L. V.; Weigel, N. L. Activation of the human androgen receptor through a protein kinase A signaling pathway. J Biol Chem 1996, 271, 19900-19907.
98. Nelson, E. C.; Cambio, A. J.; Yang, J. C.; Lara, P. N. J.; Evans, C. P. Biologic agents as adjunctive therapy for prostate cancer: A rationale for use with androgen deprivation. Nat Clin Pract Urol 2007, 4, 82-94.
99. O’Farrell, P. H. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975, 250, 4007-4021.
100. Ong, S. E.; Blagoev, B.; Kratchmarova, I.; Kristensen, D. B.; Steen, H.; Pandey, A.; Mann, M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 2002, 1, 376-386.
101. Ong, S. E.; Mann, M. Stable isotope labeling by amino acids in cell culture for quantitative proteomics. Methods Mol Biol 2007, 359, 37-52.
102. Ornstein, D. K.; Englert, C.; Gillespie, J. W.; Paweletz, C. P.; Linehan, W. M.; Emmert-Buck, M. R.; Petricoin, E. F. 3rd. Characterization of intracellular prostate-specific antigen from laser capture microdissected benign and malignant prostatic epithelium. Clin Cancer Res 2000, 6, 353-356.
103. Ornstein, D. K.; Gillespie, J. W.; Paweletz, C. P.; Duray, P. H.; Herring, J.; Vocke, C. D.; Topalian, S. L.; Bostwick, D. G.; Linehan, W. M.; Petricoin, E. F. 3rd.; Emmert-Buck, M. R. Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines. Electrophoresis 2000, 21, 2235-2242.
104. Ozers, M. S.; Marks, B. D.; Gowda, K.; Kupcho, K. R.; Ervin, K. M.; De Rosier, T.; Qadir, N.; Eliason, H. C.; Riddle, S. M.; Shekhani, M. S. The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay. Biochemistry 2007, 46, 683-695.
105. Parmley, S. F.; Smith, G. P. Filamentous fusion phage cloning vectors for the study of epitopes and design of vaccines. Adv Exp Med Biol 1989, 251, 215-218.
106. Paul, B.; Dhir, R.; Landsittel, D.; Hitchens, M. R.; Getzenberg, R. H. Detection of prostate cancer with a blood-based assay for early prostate cancer antigen. Cancer Res 2005, 65, 4097-4100.
107. Paweletz, C. P.; Liotta, L. A.; Petricoin, E. F. 3rd. New technologies for biomarker analysis of prostate cancer progression: Laser capture microdissection and tissue proteomics. Urology 2001, 57, 160-163.
108. Petricoin, E. F. 3rd.; Ornstein, D. K.; Paweletz, C. P.; Ardekani, A.; Hackett, P. S.; Hitt, B. A.; Velassco, A.; Trucco, C.; Wiegand, L.; Wood, K.; Simone, C. B.; Levine, P. J.; Linehan, W. M.; Emmert-Buck, M. R.; Steinberg, S. M.; Kohn, E. C.; Liotta, L. A. Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst 2002a, 94, 1576-1578.
109. Petricoin, E. F.; Ardekani, A. M.; Hitt, B. A.; Levine, P. J.; Fusaro, V. A.; Steinberg, S. M.; Mills, G. B.; Simone, C.; Fishman, D. A.; Kohn, E. C.; Liotta, L. A. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002b, 359, 572-577.
110. Piehler, J. New methodologies for measuring protein interactions in vivo and in vitro. Curr Opin Struct Biol 2005, 15, 4-14.
111. Popov, V. M.; Wang, C.; Shirley, L. A.; Rosenberg, A.; Li, S.; Nevalainen, M.; Fu, M.; Pestell, R. G. The functional significance of nuclear receptor acetylation. Steroids 2007, 72, 221-230.
112. Poukka, H.; Karvonen, U.; Janne, O. A.; Palvimo, J. J. Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proc Natl Acad Sci USA 2000, 97, 14145-14150.
113. Powell, I. J. Epidemiology and pathophysiology of prostate cancer in African-American men. J Urol 2007, 177, 444-449.
114. Purbey, P. K.; Jayakumar, P. C.; Deepalakshmi, P. D.; Patole, M. S.; Galande, S. GST fusion vector with caspase-6 cleavage site for removal of fusion tag during column purification. Biotechniques 2005, 38, 360-364.
115. Qin, S.; Ferdinand, A. S.; Richie, J. P.; O’Leary, M. P.; Mok, S. C.; Liu, B. C. Chromatofocusing fractionation and two-dimensional difference gel electrophoresis for low abundance serum proteins. Proteomics 2005, 5, 3183-3192.
116. Qu, Y.; Adam, B. L.; Yasui, Y.; Ward, M. D.; Cazares, L. H.; Schellhammer, P. F.; Feng, Z.; Semmes, O. J.; Wright, G. L. Jr. Boosted decision tree analysis of surface-enhanced laser desorption/ion ization mass spectral serum profiles discriminates prostate cancer from noncancer patients. Clin Chem 2002, 48, 1835-1843.
117. Quayle, S. N.; Mawji, N. R.; Wang, J.; Sadar, M. D. Decoy molecules of the androgen receptor block the growth of prostate cancer. Proc Natl Acad Sci USA 2007, 104, 1331-1336.
118. Rai, A. J.; Chan, D. W. Cancer proteomics: Serum diagnostics for tumor marker discovery. Ann N Y Acad Sci 2004, 1022, 286-294.
119. Ratnala, V. R.; Swarts, H. G.; Van Oostrum, J.; Leurs, R.; De Groot, H. J.; Bakker, R. A.; De Grip, W. J. Large-scale overproduction, functional purification and ligand affinities of the His-tagged human histamine H1 receptor. Eur J Biochem 2004, 271, 2636-2646.
120. Reid, J.; Kelly, S. M.; Watt, K.; Price, N. C.; Mc Ewan, I. J. Conformational analysis of the androgen receptor amino-terminal domain involved in transactivation. Influence of structure-stabilizing solutes and protein-protein interactions. J Biol Chem 2002, 277, 20079-20086.
121. Reiter, R. E.; Gu, Z.; Watabe, T.; Thomas, G.; Szigeti, K.; Davis, E.; Wahl, M.; Nisitani, S.; Yamashiro, J.; Le Beau, M. M.; Loda, M.; Witte, O. N. Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer. Proc Natl Acad Sci 1998, 95, 1735-1740.
122. Rogers, C. G.; Yan, G.; Zha, S.; Gonzalgo, M. L.; Isaacs, W. B.; Luo, J.; De Marzo, A. M.; Nelson, W. G.; Pavlovich, C. P. Prostate cancer detection on urinalysis for alpha methylacyl coenzyme a racemase protein. J Urol 2004, 172, 1501-1503.
123. Romanov, V. I.; Durand, D. B.; Petrenko, V. A. Phage display selection of peptides that affect prostate carcinoma cells attachment and invasion. Prostate 2001, 47, 239-251.
124. Ross, P. L.; Huang, Y. N.; Marchese, J. N.; Williamson, B.; Parker, K.; Hattan, S.; Khainovski, N.; Pillai, S.; Dey, S.; Daniels, S.; Purkayastha, S.; Juhasz, P.; Martin, S.; Bartlet-Jones, M.; He, F.; Jacobson, A.; Pappin, D. J. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 2004, 3, 1154-1169.
125. Rowland, J. G.; Robson, J. L.; Simon, W. J.; Leung, H. Y.; Slabas, A. R. Evaluation of an in vitro model of androgen ablation and identification of the androgen responsive proteome in LNCaP cells. Proteomics 2007, 7, 47-63.
126. Sadar, M. D. Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways. J Biol Chem 1999, 274, 7777-7783.
127. Sadar, M. D.; Gleave, M. E. Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells. Cancer Res 2000, 60, 5825-5831.
128. Sassenfeld, H. M.; Brewer, S. J. A polypeptide fusion designed for purification of recombinant proteins. Bio/Technology 1984, 2, 76-81.
129. Scott, J. K.; Smith, G. P. Searching for peptide ligands with an epitope library. Science 1990, 249, 386-390.
130. Scheich, C.; Sievert, V.; Bussow, K. An automated method for highthroughput protein purification applied to a comparison of His-tag and GST-tag affinity chromatography. BMC. Biotechnol 2003, 3, 12.
131. Sherwood, E. R.; Berg, L. A.; Mc Ewan, R. N.; Pasciak, R. M.; Kozlowski, J. M.; Lee, C. Two-dimensional protein profiles of cultured stromal and epithelial cells from hyperplastic human prostate. J Cell Biochem 1989, 40, 201-214.
132. Schaufele, F.; Carbonell, X.; Guerbadot, M.; Borngraeber, S.; Chapman, M. S.; Ma, A. A.; Miner, J. N.; Diamond, M. I. The structural basis of androgen receptor activation: Intramolecular and intermolecular amino-carboxy interactions. Proc Natl Acad Sci USA 2005, 102, 9802-9807.
133. Schuster, M.; Wasserbauer, E.; Einhauer, A.; Ordner, C.; Jungbauer, A.; Hammerschmidt, F.; Werner, G. Protein expression strategies for identification of novel target proteins. J Biomol Screen 2000, 5, 89-97.
134. Sharma, S. S.; Chong, S.; Harcum, S. W. Simulation of large-scale production of a soluble recombinant protein expressed in Escherichia coli using an intein-mediated purification system. Appl Biochem Biotechnol 2005, 126, 93-118.
135. Skerra, A.; Schmidt, T. G. M. Use of the Strep-tag and streptavidin for detection and purification of recombinant proteins. Methods Enzymol 2000, 326, 271-304.
136. Slootstra, J. W.; Kuperus, D.; Pluckthun, A.; Meloen, R. H. Identification of new tag sequences with differential and selective recognition properties for the anti-FLAG monoclonal antibodies M1, M2 and M5. Mol Divers 1997, 2, 156-164.
137. Smyth, D. R.; Mrozkiewicz, M. K.; McGrath, W. J.; Listwan, P.; Kobe, B. Crystal structures of fusion proteins with large-affinity tags. Protein Sci 2003, 12, 1313-1322.
138. Soares, H. D.; Williams, S. A.; Snyder, P. J.; Gao, F.; Stiger, T.; Rohlff, C.; Herath, A.; Sunderland, T.; Putnam, K.; White, W. F. Proteomic approaches in drug discovery and development. Int Rev Neurobiol 2004, 61, 97-126.
139. Söderholm, A. A.; Lehtovuori, P. T.; Nyrönen, T. H. Three-dimensional structure-activity relationships of nonsteroidal ligands in complex with androgen receptor ligand-binding domain. J Med Chem 2005, 48, 917-925.
140. Sreekumar, A.; Laxman, B.; Rhodes, D. R.; Bhagavathula, S.; Harwood, J.; Giacherio, D.; Ghosh, D.; Sanda, M. G.; Rubin, M. A.; Chinnaiyan, A. M. Humoral immune response to alpha-methylacyl-CoA racemase and prostate cancer. J Natl Cancer Inst 2004, 96, 834-843.
141. Stacewicz-Sapuntzakis, M.; Borthakur, G.; Burns, J. L.; Bowen, P. E. Correlations of dietary patterns with prostate health. Mol Nutr Food Res 2008, 52(1), 114-130.
142. Stastná, M.; Slais, K. Two-dimensional gel isoelectric focusing. Electrophoresis 2005, 26, 3586-3591.
143. Stephan, C.; Jung, K.; Lein, M.; Sinha, P.; Schnorr, D.; Loening, S. A. Molecular forms of prostate-specific antigen and human kallikrein 2 as promising tools for early diagnosis of prostate cancer. Cancer Epidemiol Biomarkers Prev 2000, 9, 1133-1147.
144. Stephan, C.; Jung, K.; Nakamura, T.; Yousef, G. M.; Kristiansen, G.; Diamandis, E. P. Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancer. Int J Urol 2006, 13, 238-243.
145. Stephens, D. J.; Banting, G. The use of yeast two-hybrid screens in studies of protein:protein interactions involved in trafficking. Traffic 2000, 1, 763-768.
146. Stewart, I. I.; Thomson, T.; Figeys, D. 18O labeling: A tool for proteomics. Rapid Commun. Mass Spectrom 2001, 15, 2456-2465.
147. Stofko-Hahn, R. E.; Carr, D. W.; Scott, J. D. A single step purification for recombinant proteins. FEBS Lett 1992, 302, 274-278.
148. Tamura, H.; Ishimoto, Y.; Fujikawa, T.; Aoyama, H.; Yoshikawa, H.; Akamatsu, M. Structural basis for androgen receptor agonists and antagonists: Interaction of SPEED 98-listed chemicals and related compounds with the androgen receptor based on an in vitro reporter gene assay and 3D-QSAR. Bioorg Med Chem 2006, 14, 7160-7174.
149. Terpe, K. Overview of tag protein fusions: From molecular and biochemical fundamentals to commercial systems. Appl Microbiol Biotechnol 2003, 60, 523-533.
150. Thompson, I. M.; Pauler, D. K.; Goodman, P. J.; Tangen, C. M.; Lucia, M. S.; Parnes, H. L.; Minasian, L. M.; Ford, L. G.; Lippman, S. M.; Crawford, E. D.; Crowley, J. J.; Coltman, C. A. Jr. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med 2004, 350, 2239-2246.
151. Toby, G. G.; Golemis, E. A. Using the yeast interaction trap and other two-hybrid-based approaches to study protein-protein interactions. Methods 2001, 24, 201-217.
152. Troyer, J. K.; Beckett, M. L.; Wright, G. L. Jr. Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids. Int J Cancer 1995, 62, 552-558.
153. Tyagi, S.; Lal, S. K. Combined transformation and genetic technique verification of protein-protein interactions in the yeast two-hybrid system. Biochem Biophys Res Commun 2000, 277, 589-593.
154. Ueda, T.; Mawji, N. R.; Bruchovsky, N.; Sadar, M. D. Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells. J Biol Chem 2002a, 277, 38087-38094.
155. Ueda, T.; Bruchovsky, N.; Sadar, M. D. Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways. J Biol Chem 2002b, 277, 7076-7085.
156. Uetz, P.; Giot, L.; Cagney, G.; Mansfield, T. A.; Judson, R. S.; Knight, J. R.; Lockshon, D.; Narayan, V.; Srinivasan, M.; Pochart, P.; Qureshi-Emili, A.; Li, Y.; Godwin, B.; Conover, D.; Kalbfleisch, T.; Vijayadamodar, G.; Yang, M.; Johnston, M.; Fields, S.; Rothberg, J. M. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 2000, 403, 623-627.
157. Unlü, M.; Morgan, M. E.; Minden, J. S. Difference gel electrophoresis: A single gel method for detecting changes in protein extracts. Electrophoresis 1997, 18, 2071-2077.
158. Utleg, A. G.; Yi, E. C.; Xie, T.; Shannon, P.; White, J. T.; Goodlett, D. R.; Hood, L.; Lin, B. Proteomic analysis of human prostasomes. Prostate 2003, 56, 150-161.
159. Vivanco, I.; Sawyers, C. L. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2002, 2, 489-501.
160. Wang, G.; Sadar, M. D. Amino-terminus domain of the androgen receptor as a molecular target to prevent the hormonal progression of prostate cancer. J Cell Biochem 2006, 98, 36-53.
161. Wang, M. C.; Papsidero, L. D.; Kuriyama, M.; Valenzuela, L. A.; Murphy, G. P.; Chu, T. M. Prostate antigen: A new potential marker for prostatic cancer. Prostate 1981, 2, 89-96.
162. Wang, Y. K.; Ma, Z.; Quinn, D. F.; Fu, E. W. Inverse 18O labeling mass spectrometry for the rapid identification of marker/target proteins. Anal Chem 2001, 73, 3742-3750.
163. Washburn, M. P.; Wolters, D.; Yates, J. R. 3rd. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 2001, 19, 242-247.
164. Wellmann, A.; Wollscheid, V.; Lu, H.; Ma, Z. L.; Albers, P.; Schütze, K.; Rohde, V.; Behrens, P.; Dreschers, S.; Ko, Y.; Wernert, N. Analysis of microdissected prostate tissue with ProteinChip arrays-a way to new insights into carcinogenesis and to diagnostic tools. Int J Mol Med 2002, 9, 341-347.
165. Wilson, D. S.; Keefe, A. D.; Szostak, J. W. The use of mRNA display to select high-affinity protein-binding peptides. Proc Natl Acad Sci USA 2001, 98, 3750-3755.
166. Witte, C. P.; Noel, L. D.; Gielbert, J.; Parker, J. E.; Romeis, T. Rapid one step protein purification from plant material using the eight-amino acid StrepII epitope. Plant Mol Biol 2004, 55, 135-147.
167. Wolf, S. S.; Patchev, V. K.; Obendorf, M. A novel variant of the putative demethylase gene, s-JMJD1C, is a coactivator of the AR. Arch Biochem Biophys 2007, 460, 56-66.
168. Wolters, D. A.; Washburn, M. P.; Yates, J. R. 3rd. An automated multidimensional protein identification technology for shotgun proteomics. Anal Chem 2001, 73, 5683-5690.
169. Wong, H. Y.; Burghoorn, J. A.; Van Leeuwen, M.; De Ruiter, P. E.; Schippers, E.; Blok, L. J.; Li, K. W.; Dekker, H. L.; De Jong, L.; Trapman, J.; Grootegoed, J. A.; Brinkmann, A. O. Phosphorylation of androgen receptor isoforms. Biochem J 2004, 383, 267-276.
170. Wright, G. W.; Cazares, L. H.; Leung, S. M.; Nasim, S.; Adam, B. L.; Yip, T. T.; Schellhammer, P. F.; Gong, L.; Vlahou, A. Proteinchip(R) surface enhanced laser desorption/ionization (SELDI) mass spectrometry: A novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer Prostatic Dis 1999, 2, 264-276.
171. Wright, M. E.; Eng, J.; Sherman, J.; Hockenbery, D. M.; Nelson, P. S.; Galitski, T.; Aebersold, R. Identification of androgen-coregulated protein networks from the microsomes of human prostate cancer cells. Genome Biol 2003, 5, R4.
172. Wu, F.; Mo, Y. Y. Ubiquitin-like protein modifications in prostate and breast cancer. Front Biosci 2007, 12, 700-711.
173. Wu, P.; Leinonen, J.; Koivunen, E.; Lankinen, H.; Stenman, U. H. Identification of novel prostate-specific antigen-binding peptides modulating its enzyme activity. Eur J Biochem 2000, 267, 6212-6220.
174. Xia, S. J.; Hao, G. Y.; Tang, X. D. Androgen receptor isoforms in human and rat prostate. Asian J Androl 2000, 2, 307-310.
175. Xiao, D.; Choi, S.; Lee, Y. J.; Singh, S. V. Role of mitogen-activated protein kinases in phenethyl isothiocyanate-induced apoptosis in human prostate cancer cells. Mol Carcinog 2005, 43, 130-140.
176. Xiao, Z.; Jiang, X.; Beckett, M.; Wright, G. L. Jr. Generation of a baculovirus recombinant prostate-specific membrane antigen and its use in the development of a novel protein biochip quantitative immunoassay. Prot Expression Purif 2000, 19, 12-21.
177. Xu, Z.; Bae, W.; Mulchandani, A.; Mehra, R. K.; Chen, W. Heavy metal removal by novel CBD-EC20 sorbents immobilized on cellulose. Biomacromolecules 2002, 3, 462-465.
178. Yan, W.; Chen, S. S. Mass spectrometry-based quantitative proteomic profiling. Brief Funct Genomic Proteomic 2005, 4, 27-38.
179. Yao, X.; Freas, A.; Ramirez, J.; Demirev, P. A.; Fenselau, C. Proteolytic 18O labeling for comparative proteomics: Model studies with two serotypes of adenovirus. Anal Chem 2004, 73, 2836-2842.
180. Yeh, S.; Chang, C. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc Natl Acad Sci USA 1996, 93, 5517-5521.
181. Yeh, S.; Miyamoto, H.; Nishimura, K.; Kang, H.; Ludlow, J.; Hsiao, P.; Wang, C.; Su, C.; Chang, C. Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells. Biochem Biophys Res Commun 1998, 248, 361-367.
182. Yi, E. C.; Li, X. J.; Cooke, K.; Lee, H.; Raught, B.; Page, A.; Aneliunas, V.; Hieter, P.; Goodlett, D. R.; Aebersold, R. Increased quantitative proteome coverage with (13)C/(12)C-based, acid-cleavable isotope-coded affinity tag reagent and modified data acquisition scheme. Proteomics 2005, 5, 380-387.
183. Zheng, Y.; Xu, Y.; Ye, B.; Lei, J.; Weinstein, M. H.; O’Leary, M. P.; Richie, J. P.; Mok, S. C.; Liu, B. C. Prostate carcinoma tissue proteomics for biomarker discovery. Cancer 2003, 98, 2576-2582.
184. Zhou, H.; Li, X. M.; Meinkoth, J.; Pittman, R. N. Akt regulates cell survival and apoptosis at a postmitochondrial level. J Cell Biol 2000, 151, 483-494.
185. Zhou, Z. X.; Kemppainen, J. A.; Wilson, E. M. Identification of three proline-directed phosphorylation sites in the human androgen receptor. Mol Endocrinol 1995, 9, 605-615.
186. Zhu, H.; Bilgin, M.; Bangham, R.; Hall, D.; Casamayor, A.; Bertone, P.; Lan, N.; Jansen, R.; Bidlingmaier, S.; Houfek, T.; Mitchell, T.; Miller, P.; Dean, R. A.; Gerstein, M.; Snyder, M. Global analysis of protein activities using proteome chips. Science 2001, 293, 2101-2105.
187. Zhu, H.; Snyder, M. Protein chip technology. Curr Opin Chem Biol 2003, 7, 55-63.
188. Zitzmann, S.; Mier, W.; Schad, A.; Kinscherf, R.; Askoxylakis, V.; Krämer, S.; Altmann, A.; Eisenhut, M.; Haberkorn, U. A new prostate carcinoma binding peptide (DUP-1) for tumor imaging and therapy. Clin Cancer Res 2005, 11, 139-146.
189. Zozulya, S.; Lioubin, M.; Hill, R. J.; Abram, C.; Gishizky, M. L. Mapping signal transduction pathways by phage display. Nat Biotechnol 1999, 17, 1193-1198.